Fundraising Fox

Clarus

Venture capital

Cambridge

Fox Verdict
Sign up to see your fit

Fund manager profile

Clarus is a venture fund manager based in Cambridge. SEC filings show 4 venture funds on record, most recently Clarus IV-C, L.P. ($880M offering) filed May 2017.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Cambridge, US
Tracked investments
10

What they invest in

from 10 of 10 portfolio companies

Biotech ×9Healthtech ×2Medical Devices ×1

HQs:United States×9

Investments · 10 tracked

founders shown can be your intro path
AnnexonNASDAQ: ANNXSEC filingmedium confidence

BiotechSo. San Francisco, US

Campbell Murray(Director)Douglas Love(Executive Officer, Director)Thomas Wiggans(Director)Emmett Cunningham(Director)Ricky Sun(Director)Muneer Satter(Director)

Board seatEmmett Cunningham· per SEC Form D · $85M raise · filed Dec 2018

CalcimedicaNASDAQ: CALCSEC filingmedium confidence

BiotechLa Jolla, US

Eric W. Roberts(Executive Officer, Director)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Kenneth A. Stauderman(Executive Officer)Sudarshan Hebbar(Executive Officer)Eric Bjerkholt(Director)

Board seatEmmett Cunningham· per SEC Form D · $80.4M raise · filed Jun 2018

Praxis Precision MedicinesNASDAQ: PRAXSEC filingmedium confidence

Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.

BiotechCambridge, US

Nicholas G. Galakatos(Director)Kiran Reddy(Executive Officer, Director)

Board seatNicholas GalakatosNicholas G. Galakatos· per SEC Form D · $10M raise · filed Jun 2019

Tectonic TherapeuticNASDAQ: TECXSEC filingmedium confidence

BiotechWatertown, US

Timothy Springer(Director)Alise Reicin(Executive Officer, Director)Daniel Lochner(Executive Officer)Marc Schwabish(Executive Officer)Peter McNamara(Executive Officer)Marcella K. Ruddy(Executive Officer)

Board seatScott Requadt· per SEC Form D · $25M raise · filed Aug 2016

Catabasis PharmaceuticalsSEC filingmedium confidence

BiotechCambridge, US

Ron Laufer(Director)Nicholas Galakatos(Director)Kenneth Bate(Director)Jill C. Milne(Executive Officer, Director)Jean George(Director)Michael Ross(Director)

Board seatNicholas Galakatos· per SEC Form D · $20.4M raise · filed Mar 2015

ESSA PharmaSEC filingmedium confidence

BiotechVancouver

Frank Perabo(Executive Officer)Franklin Berger(Director)Raymond Andersen(Executive Officer, Director)Scott Requadt(Director)Paul Cossum(Executive Officer)David Wood(Executive Officer)

Board seatScott Requadt· per SEC Form D · $15M raise · filed Jan 2016

Flowonix MedicalSEC filingmedium confidence

HealthtechMt Olive, US

Steven C. Adler(Director)David Jenkins(Director)Louis Altieri(Executive Officer)Kurt Wheeler(Director)Donald P. Carson(Director)Larry Heaton(Executive Officer)

Board seatKurt Wheeler· per SEC Form D · $15M raise · filed Jun 2016

Silk TechnologiesSEC filingmedium confidence

BiotechPlymouth, US

Emmett Jr. Cunningham(Director)Brian Lawrence(Executive Officer, Director)Mark D Dacko(Executive Officer)Brian Levy(Director)William M Mower(Director)Alex Soltani(Director)

Board seatEmmett Jr. Cunningham· per SEC Form D · $11.2M raise · filed Oct 2017

VBI Vaccines Inc/BCSEC filingmedium confidence

BiotechCambridge, US

MICHEL DE WILDE(Director)DAVID ANDERSON(CHIEF SCIENTIFIC OFFICER)ADAM LOGAL(Director)JAMES MARTIN(CHIEF FINANCIAL OFFICER)STEVEN RUBIN(Director)STEVEN GILLIS(Director)

Board seatScott Requadt· per SEC Form D · $7M raise · filed Dec 2018

Venus Conceptvenusconcept.comin𝕏SEC filingmedium confidence

Venus Concept designs and manufactures medical aesthetic devices for dermatology and cosmetic procedures.

BiotechHealthtechMedical DevicesToronto, US

Kirk Gunhus(Executive Officer)Ross Portaro(Executive Officer)Anna Georgiadis(Executive Officer)Melissa Kang(Executive Officer)Michael Mandarello(Executive Officer)Avinash Amin(Director)

Board seatEmmett CunninghamEmmett Cunningham, Jr.· per SEC Form D · $26M raise · filed Aug 2017

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Fund performance · per public LP disclosures · 2

as of Sep 2021
FundVintageCommittedNet IRRTVPIDPI
Clarus Lifesciences II, L.P.LPs: California Public Employees' Retirement System200814.7%1.84x1.79x
Clarus Lifesciences I, L.P.LPs: California Public Employees' Retirement System, Michigan Municipal Employees' Retirement System20064.0%1.26x1.15x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

Where is Clarus located?
Clarus is headquartered in Cambridge, US.

Featured in lists